HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Characteristics of group A streptococcal meningitis in children].

Abstract
Group A streptococcal (GAS) meningitis in children are rare. The aim of this study was to analyze the clinical, biological and outcome data on GAS meningitis recorded in the Bacterial Meningitis (BM) French Surveillance Network (GPIP/ACTIV). From 2001 through 2012, 4,564 children suffering from proven bacterial meningitis were recorded in the data base. Among them, 0.7 % were GAS infections. The median age was 5.6 years. A history of community acquired infection before the onset of GAS meningitis was frequent. Apart from the identification of the bacterial species, GAS meningitis were clinically and biologically indistinguishable from meningitis caused by other pathogens notably S. pneumoniae. Case fatality rate was 8 %.
AuthorsC Levy, Ph Bidet, S Bonacorsi, S Béchet, R Cohen
JournalArchives de pediatrie : organe officiel de la Societe francaise de pediatrie (Arch Pediatr) Vol. 21 Suppl 2 Pg. S101-3 (Nov 2014) ISSN: 1769-664X [Electronic] France
Vernacular TitleCaractéristiques des méningites à streptocoque du groupe A de l'enfant.
PMID25456677 (Publication Type: English Abstract, Journal Article, Multicenter Study)
CopyrightCopyright © 2014 Elsevier Masson SAS. All rights reserved.
Chemical References
  • Anti-Bacterial Agents
Topics
  • Adolescent
  • Anti-Bacterial Agents (therapeutic use)
  • Child
  • Child, Preschool
  • Female
  • France (epidemiology)
  • Genotype
  • Humans
  • Immunocompromised Host
  • Infant
  • Male
  • Meningitis, Bacterial (epidemiology, microbiology)
  • Seizures (epidemiology)
  • Shock, Septic (epidemiology)
  • Streptococcal Infections (drug therapy, epidemiology)
  • Streptococcus pyogenes (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: